SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'PAM'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CBR_A_REAA200_1 (CELLULAR RETINOICACID BINDING PROTEINTYPE I) |
5bvt | EPIDERMAL FATTYACID-BINDING PROTEIN (Pygoscelispapua) | 5 / 12 | ALA A 39PRO A 41THR A 56ARG A 130TYR A 132 | PAM A 201 (-3.3A)PAM A 201 ( 4.8A)NonePAM A 201 ( 4.6A)None | 1.09A | 1cbrA-5bvtA:18.9 | 1cbrA-5bvtA:38.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CBR_A_REAA200_1 (CELLULAR RETINOICACID BINDING PROTEINTYPE I) |
5bvt | EPIDERMAL FATTYACID-BINDING PROTEIN (Pygoscelispapua) | 5 / 12 | PHE A 19PRO A 41THR A 56ARG A 130TYR A 132 | PAM A 201 ( 4.9A)PAM A 201 ( 4.8A)NonePAM A 201 ( 4.6A)None | 0.73A | 1cbrA-5bvtA:18.9 | 1cbrA-5bvtA:38.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CBR_B_REAB200_1 (CELLULAR RETINOICACID BINDING PROTEINTYPE I) |
5bvt | EPIDERMAL FATTYACID-BINDING PROTEIN (Pygoscelispapua) | 5 / 12 | ALA A 39PRO A 41THR A 56ARG A 130TYR A 132 | PAM A 201 (-3.3A)PAM A 201 ( 4.8A)NonePAM A 201 ( 4.6A)None | 1.09A | 1cbrB-5bvtA:18.9 | 1cbrB-5bvtA:38.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CBR_B_REAB200_1 (CELLULAR RETINOICACID BINDING PROTEINTYPE I) |
5bvt | EPIDERMAL FATTYACID-BINDING PROTEIN (Pygoscelispapua) | 5 / 12 | PHE A 19PRO A 41THR A 56ARG A 130TYR A 132 | PAM A 201 ( 4.9A)PAM A 201 ( 4.8A)NonePAM A 201 ( 4.6A)None | 0.73A | 1cbrB-5bvtA:18.9 | 1cbrB-5bvtA:38.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CBS_A_REAA200_1 (CELLULAR RETINOICACID BINDING PROTEINTYPE II) |
5bvt | EPIDERMAL FATTYACID-BINDING PROTEIN (Pygoscelispapua) | 5 / 12 | PHE A 19PRO A 41THR A 56ARG A 130TYR A 132 | PAM A 201 ( 4.9A)PAM A 201 ( 4.8A)NonePAM A 201 ( 4.6A)None | 0.76A | 1cbsA-5bvtA:18.7 | 1cbsA-5bvtA:38.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1LIN_A_TFPA154_1 (CALMODULIN) |
6c0b | FRIZZLED-2TOXIN B (Clostridioidesdifficile;Homosapiens) | 4 / 7 | LEU B 124MET A1437LEU A1433GLU A1471 | PAM B 202 ( 4.6A)PAM B 202 (-3.6A)PAM B 202 (-4.2A)None | 0.94A | 1linA-6c0bB:undetectable | 1linA-6c0bB:18.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1MX8_A_RTLA135_0 (CELLULARRETINOL-BINDINGPROTEIN I, HOLO) |
3pp6 | SODIUM-CALCIUMEXCHANGER (Doryteuthispealeii) | 5 / 12 | PHE A 17TYR A 20ALA A 34PRO A 39THR A 54 | NoneNonePAM A 133 ( 3.7A)PAM A 133 (-4.4A)PAM A 133 ( 3.9A) | 0.98A | 1mx8A-3pp6A:17.7 | 1mx8A-3pp6A:35.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RU9_H_BEZH601_0 (IMMUNOGLOBULINIGG2A, HEAVY CHAINIMMUNOGLOBULINIGG2A, LIGHT CHAIN) |
3leo | LEUKOTRIENE C4SYNTHASE (Homosapiens) | 5 / 9 | ALA A 10LEU A 14GLY A 15PHE A 63GLY A 83 | PAM A 215 (-3.7A)PAM A 215 (-3.9A)NoneNoneNone | 1.34A | 1ru9H-3leoA:undetectable1ru9L-3leoA:undetectable | 1ru9H-3leoA:21.331ru9L-3leoA:16.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RUA_H_BEZH601_0 (IMMUNOGLOBULINIGG2A, HEAVY CHAINIMMUNOGLOBULINIGG2A, LIGHT CHAIN) |
3leo | LEUKOTRIENE C4SYNTHASE (Homosapiens) | 5 / 10 | ALA A 10LEU A 14GLY A 15PHE A 63GLY A 83 | PAM A 215 (-3.7A)PAM A 215 (-3.9A)NoneNoneNone | 1.35A | 1ruaH-3leoA:undetectable1ruaL-3leoA:undetectable | 1ruaH-3leoA:21.331ruaL-3leoA:16.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CBR_A_A80A201_1 (PROTEIN (CRABP-I)) |
5bvt | EPIDERMAL FATTYACID-BINDING PROTEIN (Pygoscelispapua) | 5 / 12 | PHE A 19THR A 56GLY A 80ARG A 130TYR A 132 | PAM A 201 ( 4.9A)NoneNonePAM A 201 ( 4.6A)None | 0.86A | 2cbrA-5bvtA:19.1 | 2cbrA-5bvtA:38.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2FR3_A_REAA300_1 (CELLULAR RETINOICACID BINDING PROTEIN2) |
5bvt | EPIDERMAL FATTYACID-BINDING PROTEIN (Pygoscelispapua) | 5 / 12 | PHE A 19PRO A 41THR A 56ARG A 130TYR A 132 | PAM A 201 ( 4.9A)PAM A 201 ( 4.8A)NonePAM A 201 ( 4.6A)None | 0.77A | 2fr3A-5bvtA:18.9 | 2fr3A-5bvtA:38.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
3pp6 | SODIUM-CALCIUMEXCHANGER (Doryteuthispealeii) | 7 / 12 | PHE A 17VAL A 26ALA A 34THR A 61ASP A 77ARG A 79ARG A 126 | NoneNonePAM A 133 ( 3.7A)PAM A 133 (-3.7A)PAM A 133 (-4.3A)NonePAM A 133 (-3.9A) | 0.26A | 2qm9A-3pp6A:23.1 | 2qm9A-3pp6A:37.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
5bvt | EPIDERMAL FATTYACID-BINDING PROTEIN (Pygoscelispapua) | 8 / 12 | PHE A 19VAL A 28SER A 58ASP A 79ARG A 81CYH A 121ARG A 130TYR A 132 | PAM A 201 ( 4.9A)NonePAM A 201 ( 3.9A)PAM A 201 (-4.0A)NonePAM A 201 ( 4.0A)PAM A 201 ( 4.6A)None | 0.55A | 2qm9A-5bvtA:24.8 | 2qm9A-5bvtA:47.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
5bvt | EPIDERMAL FATTYACID-BINDING PROTEIN (Pygoscelispapua) | 6 / 12 | VAL A 28SER A 58ASP A 79CYH A 128ARG A 130TYR A 132 | NonePAM A 201 ( 3.9A)PAM A 201 (-4.0A)NonePAM A 201 ( 4.6A)None | 1.43A | 2qm9A-5bvtA:24.8 | 2qm9A-5bvtA:47.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
5bvt | EPIDERMAL FATTYACID-BINDING PROTEIN (Pygoscelispapua) | 5 / 12 | VAL A 28THR A 56ASP A 79ARG A 81CYH A 121 | NoneNonePAM A 201 (-4.0A)NonePAM A 201 ( 4.0A) | 1.07A | 2qm9A-5bvtA:24.8 | 2qm9A-5bvtA:47.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_2 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
5bvt | EPIDERMAL FATTYACID-BINDING PROTEIN (Pygoscelispapua) | 4 / 4 | TYR A 22MET A 23PRO A 41ILE A 108 | NonePAM A 201 ( 3.8A)PAM A 201 ( 4.8A)PAM A 201 ( 4.7A) | 0.41A | 2qm9A-5bvtA:24.8 | 2qm9A-5bvtA:47.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
3pp6 | SODIUM-CALCIUMEXCHANGER (Doryteuthispealeii) | 6 / 12 | PHE A 17TYR A 20VAL A 26THR A 61ARG A 79ARG A 126 | NoneNoneNonePAM A 133 (-3.7A)NonePAM A 133 (-3.9A) | 0.43A | 2qm9B-3pp6A:23.8 | 2qm9B-3pp6A:37.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
5bvt | EPIDERMAL FATTYACID-BINDING PROTEIN (Pygoscelispapua) | 5 / 12 | PHE A 19TYR A 22SER A 63ILE A 108CYH A 121 | PAM A 201 ( 4.9A)NoneNonePAM A 201 ( 4.7A)PAM A 201 ( 4.0A) | 1.25A | 2qm9B-5bvtA:25.2 | 2qm9B-5bvtA:47.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
5bvt | EPIDERMAL FATTYACID-BINDING PROTEIN (Pygoscelispapua) | 9 / 12 | PHE A 19TYR A 22VAL A 28SER A 58ARG A 81ILE A 108CYH A 121ARG A 130TYR A 132 | PAM A 201 ( 4.9A)NoneNonePAM A 201 ( 3.9A)NonePAM A 201 ( 4.7A)PAM A 201 ( 4.0A)PAM A 201 ( 4.6A)None | 0.49A | 2qm9B-5bvtA:25.2 | 2qm9B-5bvtA:47.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
5bvt | EPIDERMAL FATTYACID-BINDING PROTEIN (Pygoscelispapua) | 6 / 12 | TYR A 22VAL A 28THR A 56ARG A 81ILE A 108CYH A 121 | NoneNoneNoneNonePAM A 201 ( 4.7A)PAM A 201 ( 4.0A) | 0.97A | 2qm9B-5bvtA:25.2 | 2qm9B-5bvtA:47.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_2 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
3pp6 | SODIUM-CALCIUMEXCHANGER (Doryteuthispealeii) | 4 / 4 | MET A 21PRO A 39ASP A 77ARG A 106 | PAM A 133 ( 3.9A)PAM A 133 (-4.4A)PAM A 133 (-4.3A)None | 0.39A | 2qm9B-3pp6A:23.8 | 2qm9B-3pp6A:37.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_2 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
5bvt | EPIDERMAL FATTYACID-BINDING PROTEIN (Pygoscelispapua) | 4 / 4 | MET A 23PRO A 41ASP A 79ARG A 110 | PAM A 201 ( 3.8A)PAM A 201 ( 4.8A)PAM A 201 (-4.0A)PAM A 201 ( 4.6A) | 0.25A | 2qm9B-5bvtA:25.2 | 2qm9B-5bvtA:47.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3A9E_B_REAB1_1 (RETINOIC ACIDRECEPTOR ALPHA) |
4mlo | TCP PILUS VIRULENCEREGULATORY PROTEIN (Vibriocholerae) | 5 / 11 | LEU A 25ILE A 222PHE A 255SER A 257VAL A 83 | NoneNoneNoneNonePAM A 304 ( 4.8A) | 1.41A | 3a9eB-4mloA:undetectable | 3a9eB-4mloA:21.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6G_A_IZPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
3pp6 | SODIUM-CALCIUMEXCHANGER (Doryteuthispealeii) | 8 / 12 | PHE A 17MET A 21VAL A 26PRO A 39ASP A 77ARG A 79ARG A 106ARG A 126 | NonePAM A 133 ( 3.9A)NonePAM A 133 (-4.4A)PAM A 133 (-4.3A)NoneNonePAM A 133 (-3.9A) | 0.44A | 3p6gA-3pp6A:23.1 | 3p6gA-3pp6A:42.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6G_A_IZPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
3pp6 | SODIUM-CALCIUMEXCHANGER (Doryteuthispealeii) | 6 / 12 | PHE A 17MET A 21VAL A 26PRO A 39CYH A 124ARG A 126 | NonePAM A 133 ( 3.9A)NonePAM A 133 (-4.4A)NonePAM A 133 (-3.9A) | 1.08A | 3p6gA-3pp6A:23.1 | 3p6gA-3pp6A:42.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6G_A_IZPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
3pp6 | SODIUM-CALCIUMEXCHANGER (Doryteuthispealeii) | 5 / 12 | PHE A 17VAL A 24PRO A 39CYH A 124ARG A 126 | NoneNonePAM A 133 (-4.4A)NonePAM A 133 (-3.9A) | 1.37A | 3p6gA-3pp6A:23.1 | 3p6gA-3pp6A:42.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6G_A_IZPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
5bvt | EPIDERMAL FATTYACID-BINDING PROTEIN (Pygoscelispapua) | 12 / 12 | PHE A 19MET A 23VAL A 28PRO A 41ASP A 79ARG A 81ILE A 108ARG A 110VAL A 119CYH A 121ARG A 130TYR A 132 | PAM A 201 ( 4.9A)PAM A 201 ( 3.8A)NonePAM A 201 ( 4.8A)PAM A 201 (-4.0A)NonePAM A 201 ( 4.7A)PAM A 201 ( 4.6A)NonePAM A 201 ( 4.0A)PAM A 201 ( 4.6A)None | 0.65A | 3p6gA-5bvtA:24.5 | 3p6gA-5bvtA:52.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6G_A_IZPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
5bvt | EPIDERMAL FATTYACID-BINDING PROTEIN (Pygoscelispapua) | 8 / 12 | PHE A 19MET A 23VAL A 28PRO A 41ASP A 79CYH A 128ARG A 130TYR A 132 | PAM A 201 ( 4.9A)PAM A 201 ( 3.8A)NonePAM A 201 ( 4.8A)PAM A 201 (-4.0A)NonePAM A 201 ( 4.6A)None | 1.08A | 3p6gA-5bvtA:24.5 | 3p6gA-5bvtA:52.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6H_A_IBPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
3pp6 | SODIUM-CALCIUMEXCHANGER (Doryteuthispealeii) | 4 / 7 | PHE A 17MET A 21ASP A 77ARG A 126 | NonePAM A 133 ( 3.9A)PAM A 133 (-4.3A)PAM A 133 (-3.9A) | 0.44A | 3p6hA-3pp6A:23.1 | 3p6hA-3pp6A:42.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6H_A_IBPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
5bvt | EPIDERMAL FATTYACID-BINDING PROTEIN (Pygoscelispapua) | 7 / 7 | PHE A 19MET A 23ASP A 79ILE A 108VAL A 119ARG A 130TYR A 132 | PAM A 201 ( 4.9A)PAM A 201 ( 3.8A)PAM A 201 (-4.0A)PAM A 201 ( 4.7A)NonePAM A 201 ( 4.6A)None | 0.46A | 3p6hA-5bvtA:24.5 | 3p6hA-5bvtA:52.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VM4_A_IZPA1_1 (FATTY ACIDALPHA-HYDROXYLASE) |
1izo | CYTOCHROME P450152A1 (Bacillussubtilis) | 4 / 5 | LEU A 78ARG A 242PRO A 243ALA A 246 | PAM A 601 ( 4.7A)PAM A 601 (-3.7A)PAM A 601 (-3.9A)PAM A 601 (-3.9A) | 0.31A | 3vm4A-1izoA:59.0 | 3vm4A-1izoA:43.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VNS_A_DVAA602_0 (NRPS ADENYLATIONPROTEIN CYTC1) |
1izo | CYTOCHROME P450152A1 (Bacillussubtilis) | 4 / 7 | ASP A 317PHE A 292GLY A 290THR A 321 | NonePAM A 601 (-4.9A)PAM A 601 ( 4.0A)None | 1.04A | 3vnsA-1izoA:undetectable | 3vnsA-1izoA:21.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VW1_B_CVIB301_0 (PUTATIVE REGULATORYPROTEIN) |
4mlo | TCP PILUS VIRULENCEREGULATORY PROTEIN (Vibriocholerae) | 5 / 12 | ILE A 58SER A 56ILE A 79LEU A 71LEU A 114 | NoneNoneNonePAM A 304 ( 4.9A)None | 1.33A | 3vw1B-4mloA:3.5 | 3vw1B-4mloA:21.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4M83_B_ERYB501_0 (OLEANDOMYCINGLYCOSYLTRANSFERASE) |
1izo | CYTOCHROME P450152A1 (Bacillussubtilis) | 5 / 11 | TRP A 193PHE A 166ILE A 244ALA A 246SER A 248 | NoneNoneHEM A 501 ( 4.7A)PAM A 601 (-3.9A)None | 1.44A | 4m83B-1izoA:undetectable | 4m83B-1izoA:23.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N16_A_CHDA301_0 (CARBONIC ANHYDRASE 2) |
3pp6 | SODIUM-CALCIUMEXCHANGER (Doryteuthispealeii) | 4 / 8 | GLN A 96PHE A 71THR A 54THR A 61 | NoneNonePAM A 133 ( 3.9A)PAM A 133 (-3.7A) | 0.91A | 4n16A-3pp6A:undetectable | 4n16A-3pp6A:16.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QZU_C_RTLC201_0 (RETINOL-BINDINGPROTEIN 2) |
3pp6 | SODIUM-CALCIUMEXCHANGER (Doryteuthispealeii) | 5 / 12 | PHE A 17MET A 21ALA A 34THR A 54LEU A 117 | NonePAM A 133 ( 3.9A)PAM A 133 ( 3.7A)PAM A 133 ( 3.9A)None | 0.66A | 4qzuC-3pp6A:21.7 | 4qzuC-3pp6A:36.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZN7_A_DESA601_1 (ESTROGEN RECEPTOR) |
3leo | LEUKOTRIENE C4SYNTHASE (Homosapiens) | 5 / 12 | LEU A 81ALA A 79LEU A 8LEU A 7LEU A 118 | PAM A 215 ( 4.5A)NoneNonePAM A 215 ( 4.1A)None | 1.13A | 4zn7A-3leoA:undetectable | 4zn7A-3leoA:21.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HBS_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
3pp6 | SODIUM-CALCIUMEXCHANGER (Doryteuthispealeii) | 6 / 12 | PHE A 17TYR A 20VAL A 26ALA A 34PRO A 39ILE A 52 | NoneNoneNonePAM A 133 ( 3.7A)PAM A 133 (-4.4A)None | 0.73A | 5hbsA-3pp6A:21.0 | 5hbsA-3pp6A:36.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M0O_A_EPAA502_1 (TERMINALOLEFIN-FORMING FATTYACID DECARBOXYLASE) |
1izo | CYTOCHROME P450152A1 (Bacillussubtilis) | 5 / 10 | LEU A 78ARG A 242PRO A 243ALA A 246PHE A 289 | PAM A 601 ( 4.7A)PAM A 601 (-3.7A)PAM A 601 (-3.9A)PAM A 601 (-3.9A)HEM A 501 ( 4.0A) | 0.30A | 5m0oA-1izoA:57.6 | 5m0oA-1izoA:42.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M0O_A_EPAA502_1 (TERMINALOLEFIN-FORMING FATTYACID DECARBOXYLASE) |
1izo | CYTOCHROME P450152A1 (Bacillussubtilis) | 5 / 10 | LEU A 78PHE A 173ARG A 242PRO A 243ALA A 246 | PAM A 601 ( 4.7A)PAM A 601 ( 4.2A)PAM A 601 (-3.7A)PAM A 601 (-3.9A)PAM A 601 (-3.9A) | 0.65A | 5m0oA-1izoA:57.6 | 5m0oA-1izoA:42.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M0O_C_EPAC502_1 (TERMINALOLEFIN-FORMING FATTYACID DECARBOXYLASE) |
1izo | CYTOCHROME P450152A1 (Bacillussubtilis) | 5 / 8 | LEU A 78ARG A 242PRO A 243ALA A 246PHE A 289 | PAM A 601 ( 4.7A)PAM A 601 (-3.7A)PAM A 601 (-3.9A)PAM A 601 (-3.9A)HEM A 501 ( 4.0A) | 0.31A | 5m0oC-1izoA:56.5 | 5m0oC-1izoA:41.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M0O_C_EPAC502_1 (TERMINALOLEFIN-FORMING FATTYACID DECARBOXYLASE) |
1izo | CYTOCHROME P450152A1 (Bacillussubtilis) | 5 / 8 | LEU A 78PHE A 173ARG A 242PRO A 243ALA A 246 | PAM A 601 ( 4.7A)PAM A 601 ( 4.2A)PAM A 601 (-3.7A)PAM A 601 (-3.9A)PAM A 601 (-3.9A) | 0.66A | 5m0oC-1izoA:56.5 | 5m0oC-1izoA:41.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TUD_A_ERMA2001_2 (5-HYDROXYTRYPTAMINERECEPTOR 2B,SOLUBLECYTOCHROME B562CHIMERA) |
3pp6 | SODIUM-CALCIUMEXCHANGER (Doryteuthispealeii) | 4 / 7 | THR A 56LYS A 22ASN A 35GLU A 15 | PAM A 133 ( 4.6A)NoneNoneNone | 0.87A | 5tudA-3pp6A:undetectable | 5tudA-3pp6A:15.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UXD_B_ZITB501_1 (MACROLIDE2'-PHOSPHOTRANSFERASE MPHH) |
6c0b | FRIZZLED-2TOXIN B (Clostridioidesdifficile;Homosapiens) | 5 / 12 | LEU A1488ASP A1490LEU A1527VAL A1518PHE B 128 | NoneNoneNoneNonePAM B 202 (-3.9A) | 1.04A | 5uxdB-6c0bA:undetectable | 5uxdB-6c0bA:12.87 |